Literature DB >> 7509428

Phospholipid analysis of alveolar macrophages and bronchoalveolar lavage fluid following bleomycin administration to rabbits.

K Yasuda1, A Sato, K Nishimura, K Chida, H Hayakawa.   

Abstract

Changes in the lipid metabolism of the lung during pulmonary injury were investigated by quantitative and qualitative analysis of phospholipids in pulmonary surfactant and alveolar macrophages (AM) obtained from rabbits that had been given a single transtracheal injection of bleomycin hydrochloride (BLM) 0, 7, 14, 21, and 28 days previously. BLM treatment increased the phospholipid content of both bronchoalveolar lavage (BAL) supernatant fluids and BAL cells. Furthermore, the proportion of phosphatidylcholine (PC) showed an increase in BAL cells during the development of pulmonary injury, and BLM treatment appeared to cause transformation of AM to foamy AM. Lipid analyses of the foamy AM revealed that their phospholipid content was increased, and that the percentage of PC with palmitic acid was elevated. Thus it appears that accumulation of phospholipids derived from pulmonary surfactant contributes to the increase in phospholipids and PC in BAL cells. These findings indicate that BLM treatment produces an alteration in the amount and composition of AM phospholipids, and also in BAL supernatant fluids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509428     DOI: 10.1007/bf00185080

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  32 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production.

Authors:  S H Phan; S L Kunkel
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

3.  Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.

Authors:  P B Bitterman; M D Wewers; S I Rennard; S Adelberg; R G Crystal
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.

Authors:  F M LaForce; W J Kelly; G L Huber
Journal:  Am Rev Respir Dis       Date:  1973-10

5.  Influence of fatty acyl substitution on the composition and function of macrophage membranes.

Authors:  E M Mahoney; W A Scott; F R Landsberger; A L Hamill; Z A Cohn
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  High-performance liquid chromatographic determination of the lecithin/sphingomyelin ratio in amniotic fluid.

Authors:  R L Briand; S Harold; K G Blass
Journal:  J Chromatogr       Date:  1981-05-08

7.  Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages.

Authors:  S O'Neill; E Lesperance; D J Klass
Journal:  Am Rev Respir Dis       Date:  1984-08

8.  Chemotactic and candidacidal responses of rabbit alveolar macrophages during postnatal development and the modulating roles of surfactant in these responses.

Authors:  B J Zeligs; L S Nerurkar; J A Bellanti
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases.

Authors:  S I Rennard; G W Hunninghake; P B Bitterman; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Surfactant alterations following acute bleomycin and hyperoxia-induced lung damage.

Authors:  M E Goad; A F Tryka; H P Witschi
Journal:  Toxicol Lett       Date:  1986-09       Impact factor: 4.372

View more
  6 in total

1.  Oxidized phosphatidylcholine in alveolar macrophages in idiopathic interstitial pneumonias.

Authors:  N Yoshimi; Y Ikura; Y Sugama; S Kayo; M Ohsawa; S Yamamoto; Y Inoue; K Hirata; H Itabe; J Yoshikawa; M Ueda
Journal:  Lung       Date:  2005 Mar-Apr       Impact factor: 2.584

2.  A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis.

Authors:  Freddy Romero; Dilip Shah; Michelle Duong; Raymond B Penn; Michael B Fessler; Jennifer Madenspacher; William Stafstrom; Mani Kavuru; Bo Lu; Caleb B Kallen; Kenneth Walsh; Ross Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

3.  Alveolar Macrophage ABCG1 Deficiency Promotes Pulmonary Granulomatous Inflammation.

Authors:  Matthew McPeek; Anagha Malur; Debra A Tokarz; Kvin Lertpiriyapong; Kymberly M Gowdy; Gina Murray; Christopher J Wingard; Michael B Fessler; Barbara P Barna; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2019-09       Impact factor: 6.914

Review 4.  Lysophosphatidic acid and renal fibrosis.

Authors:  Jean-Philippe Pradère; Julien Gonzalez; Julie Klein; Philippe Valet; Sandra Grès; David Salant; Jean-Loup Bascands; Jean-Sébastien Saulnier-Blache; Joost P Schanstra
Journal:  Biochim Biophys Acta       Date:  2008-04-11

5.  Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs.

Authors:  Kristin Öhlinger; Markus Absenger-Novak; Claudia Meindl; Jennifer Ober; Eleonore Fröhlich
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

Review 6.  Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways.

Authors:  Vidyani Suryadevara; Ramaswamy Ramchandran; David W Kamp; Viswanathan Natarajan
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.